Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
CNY 33.93
(-0.73%)
CNY 33.93
(-0.73%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 7.5 Billion CNY | 0.04% |
| 2022 | 7.41 Billion CNY | -6.18% |
| 2021 | 7.9 Billion CNY | 8.41% |
| 2020 | 7.29 Billion CNY | -17.13% |
| 2019 | 8.8 Billion CNY | 13.23% |
| 2018 | 7.77 Billion CNY | 68.38% |
| 2017 | 4.61 Billion CNY | 75.86% |
| 2016 | 2.62 Billion CNY | 21.29% |
| 2015 | 2.16 Billion CNY | 9.56% |
| 2014 | 1.97 Billion CNY | 19.82% |
| 2013 | 1.64 Billion CNY | 29.35% |
| 2012 | 1.27 Billion CNY | 12.95% |
| 2011 | 1.12 Billion CNY | 27.26% |
| 2010 | 886.82 Million CNY | 26.93% |
| 2009 | 698.67 Million CNY | 28.25% |
| 2008 | 544.79 Million CNY | 21.97% |
| 2007 | 446.66 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 4.32 Billion CNY | 117.83% |
| 2024 Q1 | 1.98 Billion CNY | 3.86% |
| 2024 Q3 | 1.57 Billion CNY | -64.17% |
| 2023 Q1 | 1.92 Billion CNY | -3.4% |
| 2023 Q4 | 1.91 Billion CNY | 0.28% |
| 2023 FY | 7.42 Billion CNY | 0.04% |
| 2023 Q3 | 1.9 Billion CNY | 3.35% |
| 2023 Q2 | 1.84 Billion CNY | -3.94% |
| 2022 Q1 | 1.97 Billion CNY | -3.75% |
| 2022 Q4 | 1.98 Billion CNY | 12.03% |
| 2022 FY | 7.41 Billion CNY | -6.18% |
| 2022 Q3 | 1.77 Billion CNY | 5.81% |
| 2022 Q2 | 1.67 Billion CNY | -15.12% |
| 2021 Q1 | 2 Billion CNY | 2.82% |
| 2021 Q3 | 2.01 Billion CNY | 9.64% |
| 2021 Q4 | 2.05 Billion CNY | 2.05% |
| 2021 Q2 | 1.83 Billion CNY | -8.51% |
| 2021 FY | 7.9 Billion CNY | 8.41% |
| 2020 FY | 7.29 Billion CNY | -17.13% |
| 2020 Q2 | 1.72 Billion CNY | 9.45% |
| 2020 Q4 | 1.95 Billion CNY | -4.04% |
| 2020 Q3 | 2.03 Billion CNY | 17.56% |
| 2020 Q1 | 1.58 Billion CNY | -35.06% |
| 2019 Q3 | 2.11 Billion CNY | -6.71% |
| 2019 Q1 | 1.98 Billion CNY | -6.6% |
| 2019 Q2 | 2.26 Billion CNY | 14.18% |
| 2019 FY | 8.8 Billion CNY | 13.23% |
| 2019 Q4 | 2.43 Billion CNY | 15.05% |
| 2018 Q1 | 1.76 Billion CNY | -6.12% |
| 2018 Q4 | 2.12 Billion CNY | -4.65% |
| 2018 Q3 | 2.23 Billion CNY | 34.65% |
| 2018 FY | 7.77 Billion CNY | 68.38% |
| 2018 Q2 | 1.65 Billion CNY | -5.96% |
| 2017 Q2 | 813.43 Million CNY | 11.26% |
| 2017 FY | 4.61 Billion CNY | 75.86% |
| 2017 Q4 | 1.87 Billion CNY | 56.8% |
| 2017 Q3 | 1.19 Billion CNY | 47.08% |
| 2017 Q1 | 731.11 Million CNY | -14.69% |
| 2016 Q4 | 856.96 Million CNY | 30.06% |
| 2016 FY | 2.62 Billion CNY | 21.29% |
| 2016 Q1 | 536.72 Million CNY | -11.54% |
| 2016 Q2 | 572.75 Million CNY | 6.71% |
| 2016 Q3 | 658.89 Million CNY | 15.04% |
| 2015 Q4 | 606.72 Million CNY | 6.32% |
| 2015 FY | 2.16 Billion CNY | 9.56% |
| 2015 Q3 | 570.65 Million CNY | 12.21% |
| 2015 Q2 | 508.57 Million CNY | 6.27% |
| 2015 Q1 | 478.58 Million CNY | -6.93% |
| 2014 Q3 | 500.59 Million CNY | 0.19% |
| 2014 Q1 | 461.25 Million CNY | 2.77% |
| 2014 FY | 1.97 Billion CNY | 19.82% |
| 2014 Q4 | 514.19 Million CNY | 2.72% |
| 2014 Q2 | 499.66 Million CNY | 8.33% |
| 2013 Q2 | 407.85 Million CNY | 11.07% |
| 2013 Q3 | 424.97 Million CNY | 4.2% |
| 2013 FY | 1.64 Billion CNY | 29.35% |
| 2013 Q4 | 448.81 Million CNY | 5.61% |
| 2013 Q1 | 367.21 Million CNY | 8.94% |
| 2012 Q3 | 350.35 Million CNY | 9.56% |
| 2012 Q1 | 267.51 Million CNY | -9.44% |
| 2012 Q4 | 337.08 Million CNY | -3.79% |
| 2012 Q2 | 319.78 Million CNY | 19.54% |
| 2012 FY | 1.27 Billion CNY | 12.95% |
| 2011 Q1 | 268.67 Million CNY | -0.79% |
| 2011 FY | 1.12 Billion CNY | 27.26% |
| 2011 Q4 | 295.41 Million CNY | 6.62% |
| 2011 Q3 | 277.08 Million CNY | -3.58% |
| 2011 Q2 | 287.37 Million CNY | 6.96% |
| 2010 Q3 | 228.54 Million CNY | 12.03% |
| 2010 Q2 | 204 Million CNY | 11.2% |
| 2010 Q1 | 183.45 Million CNY | -2.14% |
| 2010 Q4 | 270.81 Million CNY | 18.49% |
| 2010 FY | 886.82 Million CNY | 26.93% |
| 2009 Q4 | 187.45 Million CNY | -6.3% |
| 2009 FY | 698.67 Million CNY | 28.25% |
| 2009 Q3 | 200.05 Million CNY | 15.9% |
| 2009 Q2 | 172.61 Million CNY | 24.6% |
| 2009 Q1 | 138.54 Million CNY | 0.0% |
| 2008 FY | 544.79 Million CNY | 21.97% |
| 2007 FY | 446.66 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 1.36 Billion CNY | -450.51% |
| Zhejiang Zhenyuan Share Co., Ltd. | 654.18 Million CNY | -1047.813% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 548.76 Million CNY | -1268.303% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 343.25 Million CNY | -2087.551% |
| Yifan Pharmaceutical Co., Ltd. | 2.82 Billion CNY | -165.434% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 307.2 Million CNY | -2344.239% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 564.68 Million CNY | -1229.729% |
| Boai NKY Medical Holdings Ltd. | 309.15 Million CNY | -2328.845% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 463.02 Million CNY | -1521.678% |